Edesa Biotech (NASDAQ:EDSA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Brookline Capital Management in a research report issued on Thursday, Benzinga reports. They currently have a $57.00 price target on the stock. Separately, HC Wainwright decreased their price target on shares of Edesa Biotech from $112.00 to […]